Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Regeneron Pharmaceuticals Inc (REGN) – Regeneron Pharmaceuticals Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Regeneron Pharmaceuticals (REGN) trades at $625.00, up 1.13% on the day, with a bullish technical signal and strong analyst support. The stock shows robust fundamentals with a P/E of 15.22, net income margin of 29.65%, and consistent earnings beats in recent quarters. Recent news highlights pipeline progress, including FDA/EMA review for cemdisiran and an expanded cancer partnership with CytomX.
The outlook remains positive with a consensus price target of $815.00 representing 30% upside. Key opportunities include continued growth from Dupixent and EYLEA HD, while risks include competitive pressures, legal investigations, and potential pipeline setbacks. Wall Street sentiment is strongly bullish with 32 buy ratings and no sell recommendations.
Read full analysis

Key Stats

  • Market Cap
    $65.36B
  • Sector
    Health
  • 3M Drawdown
    -22.72%
  • Enterprise Value
    $59.31B
  • Dividend Yield
    0.6%
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    99 days
$627.09
52W Low: $520.29
25 Jun 2025
52W High: $812.27
07 Jan 2026

Regeneron Pharmaceuticals Inc (REGN) is currently valued at a market capitalization of $65.36B, with an enterprise value of $59.31B. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $520.29 and a high of $812.27, highlighting its annual price range. Over the past three months, Regeneron Pharmaceuticals Inc has recorded a drawdown of -22.72%, reflecting recent price volatility. Regeneron Pharmaceuticals Inc offers a dividend yield of 0.6%, with the most recent dividend of $0.94 paid on 20 May 26. On average, investors hold Regeneron Pharmaceuticals Inc for approximately 99 days, indicating typical investor behavior on the platform.

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases


People also bought


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $65.36B
  • Sector
    Health
  • 3M Drawdown
    -22.72%
  • Enterprise Value
    $59.31B
  • Dividend Yield
    0.6%
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    99 days
$627.09
52W Low: $520.29
25 Jun 2025
52W High: $812.27
07 Jan 2026

Regeneron Pharmaceuticals Inc (REGN) is currently valued at a market capitalization of $65.36B, with an enterprise value of $59.31B. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $520.29 and a high of $812.27, highlighting its annual price range. Over the past three months, Regeneron Pharmaceuticals Inc has recorded a drawdown of -22.72%, reflecting recent price volatility. Regeneron Pharmaceuticals Inc offers a dividend yield of 0.6%, with the most recent dividend of $0.94 paid on 20 May 26. On average, investors hold Regeneron Pharmaceuticals Inc for approximately 99 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!